tiprankstipranks
Trending News
More News >
Harmony Biosciences Holdings (HRMY)
NASDAQ:HRMY
US Market

Harmony Biosciences Holdings (HRMY) Income Statement

Compare
255 Followers

Harmony Biosciences Holdings Income Statement

Last quarter (Q4 2024), Harmony Biosciences Holdings's total revenue was $201.27M, an increase of 19.51% from the same quarter last year. In Q4, Harmony Biosciences Holdings's net income was $49.48M. See Harmony Biosciences Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 714.73M$ 582.02M$ 437.86M$ 305.44M$ 159.74M
Gross Profit
$ 557.92M$ 460.79M$ 354.37M$ 249.92M$ 132.00M
Operating Expenses
$ 367.09M$ 268.76M$ 234.19M$ 162.39M$ 115.02M
Depreciation and Amortization
$ 24.11M$ 24.36M$ 23.39M$ 18.84M$ 10.24M
EBITDA
$ 233.41M$ 221.51M$ 143.57M$ 106.37M$ 1.51M
Operating Income
$ 190.83M$ 192.03M$ 120.19M$ 68.70M$ 3.68M
Other Income/Expenses
$ 978.00K$ -18.63M$ -15.50M$ -50.10M$ -53.93M
Pretax Income
$ 191.80M$ 173.40M$ 104.69M$ 37.43M$ -36.94M
Net Income
$ 145.49M$ 128.85M$ 181.47M$ 34.60M$ -51.86M
Per Share Metrics
Basic EPS
$ 2.56$ 2.17$ 3.07$ 0.60$ -0.91
Diluted EPS
$ 2.51$ 2.13$ 2.97$ 0.58$ -0.91
Weighted Average Shares Outstanding
56.89M 59.47M 59.17M 57.53M 56.89M
Weighted Average Shares Outstanding (Diluted)
57.87M 60.37M 61.10M 59.21M 56.89M
Currency in USD

Harmony Biosciences Holdings Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis